DXB.AU DIMERIX LTD
Closed 05-03 16:12:00 AEST
0.36
+0.03
+7.46%
High0.36Low0.34Vol10.74M
Open0.34D1 Closing0.34Amplitude8.06%
Mkt Cap197.86MTradable Cap143.46MTotal Shares549.60M
T/O3.80MT/O Rate2.70%Tradable Shares398.49M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
BRIEF-Dimerix Receives PIP Approval From UK Medicines And Healthcare Products Regulatory Agency
Reuters  ·  05-01 08:41
BRIEF-Dimerix Receives PIP Approval From UK Medicines And Healthcare Products Regulatory Agency
The 10-bagger battery metals play (and how this fundie found it)
LiveWire  ·  04-18
The 10-bagger battery metals play (and how this fundie found it)
BUZZ-Australia's Dimerix hits highest in 2-1/2 years on placement
Reuters  ·  03-12
BUZZ-Australia's Dimerix hits highest in 2-1/2 years on placement
BRIEF-Dimerix Announces Placement To Raise A$20 Million At Issue Price Of A$0.30 Per Share
Reuters  ·  03-12
BRIEF-Dimerix Announces Placement To Raise A$20 Million At Issue Price Of A$0.30 Per Share
Dimerix (ASX:DXB) secures $20M boost for ACTION3 trial advancement in FSGS treatment
Grafa  ·  03-12
Dimerix (ASX:DXB) secures $20M boost for ACTION3 trial advancement in FSGS treatment
Market Open: Backwards step to start a new week
The Market Herald  ·  03-11
Market Open: Backwards step to start a new week
BRIEF-Dimerix Seeks Trading Halt
Reuters  ·  03-11
BRIEF-Dimerix Seeks Trading Halt
Calculating The Intrinsic Value Of Dimerix Limited (ASX:DXB)
Simply Wall St.  ·  02-28
Calculating The Intrinsic Value Of Dimerix Limited (ASX:DXB)
BRIEF-Dimerix Ltd Posts HY Loss Attributable Of A$6.7 Million
Reuters  ·  02-26
BRIEF-Dimerix Ltd Posts HY Loss Attributable Of A$6.7 Million
Press Release: Scotia Global Asset Management honoured to receive 21 awards at 2023 FundGrade A+® Awards
Dow Jones  ·  02-02
Press Release: Scotia Global Asset Management honoured to receive 21 awards at 2023 FundGrade A+® Awards
Is Dimerix (ASX:DXB) Using Too Much Debt?
Simply Wall St.  ·  2023-12-19
Is Dimerix (ASX:DXB) Using Too Much Debt?
BUZZ-Dimerix jumps on China nod for recruitment for kidney disease drug study
Reuters  ·  2023-11-28
BUZZ-Dimerix jumps on China nod for recruitment for kidney disease drug study
Dimerix gains NMPA approval for IND, opening doors to global phase three tudy on FSGS Treatment
The Market Herald  ·  2023-11-28
Dimerix gains NMPA approval for IND, opening doors to global phase three tudy on FSGS Treatment
BRIEF-Dimerix Says Investigational New Drug Application For DMX-200 Approved
Reuters  ·  2023-11-28
BRIEF-Dimerix Says Investigational New Drug Application For DMX-200 Approved
Dimerix secures $10.7m upfront payment from Advanz Pharma
The Market Herald  ·  2023-11-06
Dimerix secures $10.7m upfront payment from Advanz Pharma

Introduction

Company Name.
DIMERIX LTD
Affiliated Markets:
ASX
Listing Date:
--
Main Business:
Dimerix Limited, a clinical stage biotechnology company, develops and commercializes new therapies in the area of unmet medical needs. Its lead product candidate is DMX-200, which is in Phase II clinical trial for the treatment of diabetic kidney diseases and focal segmental glomerulosclerosis. The company is headquartered in Fitzroy, Australia.
Issue price:
--